Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome.

Biochemical and biophysical research communications - 23 Mar 2012

Iriyama Chisako, Tomita Akihiro, Hoshino Hideaki, Adachi-Shirahata Mizuho, Furukawa-Hibi Yoko, Yamada Kiyofumi, Kiyoi Hitoshi, Naoe Tomoki

Abstract excerpt

Myelodysplastic syndrome (MDS) is a hematopoietic stem cell disorder. Several genetic/epigenetic abnormalities are deeply associated with the pathogenesis of MDS. Although bone marrow (BM) aspiration is a common strategy to obtain MDS cells for evaluating their genetic/epigenetic abnormalities, B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CpG Islands
Share to DNA
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Epigenesis, Genetic

Share to Genetic Markers

Share to Long Interspersed Nucleotide Elements

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 22382018
DOI: 10.1016/j.bbrc.2012.02.071

Genes

TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22382018-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome.PMID 22382018Read ↗

Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.Semantic proximity Read ↗

DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic SyndromeSemantic proximity Read ↗

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.Semantic proximity Read ↗

Acquired mutations in TET2 are common in myelodysplastic syndromes.Semantic proximity Read ↗

Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome.Semantic proximity Read ↗

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemiaSemantic proximity Read ↗

Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic SyndromeSemantic proximity Read ↗

Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndromeSemantic proximity Read ↗

Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patientsSemantic proximity Read ↗

Implementation of advanced analytical methods MeD-seq and LC-MS/MS for assessing the epigenetic profile of high-risk myelodysplastic syndromeSemantic proximity Read ↗

DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic SyndromesSemantic proximity Read ↗

DNA methylation in hematopoietic development and disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.